Healthcare

Survey: 40% of Americans’ Daily Lives are Disrupted by Digestive Troubles

BETHESDA, Md.—In September, the American Gastroenterological Association (AGA) launched Trust Your Gut, an awareness campaign aimed at shortening the time from the onset of bowel symptoms to discussions with a healthcare provider. As part of the campaign, AGA released new data that shows nearly 40% of Americans have stopped routine activities in the last year due to uncomfortable bowel symptoms, ...

Read More »

2022 Gastroparesis Awareness Month: The Burdens, Concerns, and Quality of Life for Individuals

MOUNT PLEASANT, S.C.—Gastroparesis Awareness Month, established by IFFGD in 2016, takes place every year during the month of August. IFFGD utilizes its platform to support the gastroparesis community by raising awareness to promote education and encourage research. Gastroparesis is a chronic gastrointestinal (GI) disorder affecting approximately 5 million people in the United States and about 38 women and 10 men ...

Read More »

FDA Alert: Change in Reprocessing Methods for Certain Karl Storz Urological Endoscopes

The U.S. Food & Drug Administration recently issued a letter to healthcare providers regarding changes to reprocessing methods for certain urological endoscopes manufactured by Karl Storz, due to infection risk. The letter can be found here. An excerpt follows: “As the U.S. Food and Drug Administration (FDA) continues to evaluate the risk of patient infections and contamination issues associated with ...

Read More »

New Study Finds Endoscopy Equipment Market Worth $39.3 Billion

Markets and Markets Logo

According to the new market research report “Endoscopy Equipment Marketby Product (Endoscope (Flexible, Rigid, Capsule, Robot-assisted, Disposable), Visualization Systems, Accessories), Application (GI Endoscopy, Laparoscopy, Bronchoscopy, Arthroscopy), End User – Global Forecast to 2026″, published by MarketsandMarkets™, the global Endoscopy Equipment Market is projected to reach USD 39.3 billion by 2026 from USD 27.3 billion in 2021, at a CAGR of 7.5%. ...

Read More »

Geneoscopy Starts Clinical Trial for Home Colorectal-Cancer Test

ST. LOUIS, Missouri—Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, today announced the enrollment of its first patients in the CRC-PREVENT pivotal trial. The clinical study seeks to evaluate the safety and efficacy of Geneoscopy’s noninvasive, at-home diagnostic screening test to successfully detect colorectal neoplasms, including advanced adenomas, in average-risk individuals, a ...

Read More »